Jean‐Pierre Delord
Inserm(FR)Institut universitaire du cancer de Toulouse Oncopole(FR)Toulouse Mathematics Institute(FR)Institut Claudius Regaud(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Head and Neck Cancer Studies
Most-Cited Works
- → Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study(2020)2,424 cited
- → Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study(2018)1,656 cited
- → Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy(2014)1,342 cited
- → Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study(2019)1,024 cited
- → Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer(2018)779 cited
- →